Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiogra
The TERdeblue-S study is a feasibility study of robotic remote echocardiography, not only in terms of technology but also in terms of its integration into a telemedicine system to improve access to the heart failure management system in the Guadeloupe archipelago. The main objective of this study is to study the agreem
| Condition(s) | Heart Failure, Remote Consultation, Teleconsultation, Echocardiography, Doppler |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The TERdeblue-S study is a feasibility study of robotic remote echocardiography, not only in terms of technology but also in terms of its integration into a telemedicine system to improve access to the heart failure management system in the Guadeloupe archipelago. The main objective of this study is to study the agreement of the measurement of the left ventricular ejection fraction (FejVG) between in situ echocardiography (EIS) and two-dimensional remote echocardiography (TER) (distance and volumes). |
| Who can participate | Inclusion Criteria: * Age ≥18 years * Free, informed and written consent signed by the participant and the investigator * Person affiliated or benefiting from a social security scheme. * Patient meeting at least one of the following criteria: * Systematic cardiovascular check-up or asymptomatic patient with cardiovascular risk factor (hypertension, diabetes, obesity, tobacco, alcohol) * Clinical suspicion of heart disease and/or chronic heart failure with stability of at least one week. * Family history of heart disease and/or sudden death Exclusion Criteria: * Patient requiring urgent cardiological management with transfer to the University Hospital * Acute unstable heart failure, admission to CH Marie-Galante less than 5 days (less than one week) * Pregnant women |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Centre Hospitalier Universitaire de la Guadeloupe |
| Locations | Grand-Bourg, Guadeloupe; Petit-Bourg, Guadeloupe; Petit-Canal, Guadeloupe |
| Start date | 2025-11-30 |
| NCT ID | NCT07265986 |
| Official listing | https://clinicaltrials.gov/study/NCT07265986 |